Biotech

All Articles

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS trials

.Sanofi is actually still set on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, exe...

Galapagos' stockpile as fund reveals intent to form its progression

.Galapagos is happening under additional pressure coming from investors. Having constructed a 9.9% r...

Cell- centered Sana gathers 1st CSO-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and...

Allist settles Jacobio $21M, landing task in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has acquired on its own a starring role in China's KRAS market, pay...

ReNeuron leaving objective swap after missing out on fundraising goal

.ReNeuron has actually participated in the long listing of biotechs to leave behind London's intenti...

MBX files for IPO to take opposition to Ascendis right into period 3

.MBX Biosciences has actually contributed to the recent outbreak of IPO filings. The biotech, which ...

FDA extends probe right into Lykos' MDMA tests: WSJ

.For Lykos Therapies as well as the business's prospective MDMA-assisted treatment for trauma (PTSD)...

Gene publisher Volume laying off 131 employees

.Merely times after gene editor Tome Biosciences revealed hidden working slices, a clearer picture i...

Repare gives up 25% of personnel as biotech halts preclinical R&ampD

.Repare Therapeutics is actually laying off a quarter of its own workforce as the oncology biotech d...

J &amp J apply for FDA authorization of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten another measure towards understanding a gain on its $6.5 billion ni...